prostate cancer
Home Up Normal organs Evaluation slide (TEST SLIDE) Various cancers Normal organs and cancers prostate cancer Breast: cancer-metastasis-normal lung cancer Lung: cancer-metastasis-normal Normal lung tissue colon and rectum cancer colorectal: cancer-metastasis-normal Normal colon and rectum tissue larynx and pharynx cancer Ovary cancer Kidney cancer Stomach cancer Normal stomach tissue Esophagus cancer Liver cancer Liver: cancer-metastasis-normal Non-neoplastic liver tissue Thyroid cancer Lipomatous tumors Skin cancer Normal endometrium

 

 

   Category Human tissue array
   Cat. No. CA
   Product description prostate cancer
   Data sheet CA3
CA3
   TNM stage prostate
   Images
  general_information
   No. of samples 49
   Text
current version: CA3
prostate cancer: 40 cores
normal prostate: 9 cores

Price : 5 slides for 600 €

CA3 Human, Prostate cancer
                 
  Age Sex Organ Diagnosis Gleason TNM Stage PSA(ng/ml)
1 60 M prostate adenocarcinoma 9 T3N0M0 11,2
2 64 M prostate adenocarcinoma 7 T2N0M0 30
3 71 M prostate adenocarcinoma 9 T3N0M0 60,4
4 64 M prostate adenocarcinoma 10 T3N0M0 7,4
5 59 M prostate adenocarcinoma 9 T3N0M0 9,8
6 65 M prostate adenocarcinoma 8 T4N0M0 34,9
7 73 M prostate adenocarcinoma 7 T2N0M0 48,1
8 69 M prostate adenocarcinoma 7 T2N0M0 10,6
9 62 M prostate adenocarcinoma 7 T2N0M0 37,3
10 66 M prostate adenocarcinoma 9 T3N0M0 1,2
11 60 M prostate adenocarcinoma 9 T3N0M0 40
12 66 M prostate adenocarcinoma 7 T3N0M0 8,4
13 70 M prostate adenocarcinoma 7 T4N0M0 7
14 65 M prostate adenocarcinoma 9 T3N0M0 17,5
15 67 M prostate adenocarcinoma 9 T3N1M0 13,1
16 69 M prostate adenocarcinoma 7 T3N0M0 1,1
17 63 M prostate adenocarcinoma 9 T3N1M0 11,8
18 69 M prostate adenocarcinoma 7 T3N0M0 17,6
19 70 M prostate adenocarcinoma 7 T3N0M0 9
20 58 M prostate adenocarcinoma 9 T3N0M0 5,8
21 58 M prostate adenocarcinoma 7 T3N0M0 15,8
22 71 M prostate adenocarcinoma 7 T2N0M0 31,4
23 70 M prostate adenocarcinoma 7 T3N0M0 14,4
24 59 M prostate adenocarcinoma 6 T2N0M0 18,3
25 63 M prostate adenocarcinoma 9 T3N0M0 16,6
26 72 M prostate adenocarcinoma 9 T3N0M0 .
27 66 M prostate adenocarcinoma 8 T3N0M0 10,8
28 70 M prostate adenocarcinoma 6 T3N0M0 10,8
29 70 M prostate adenocarcinoma 7 T2N0M0 .
30 68 M prostate adenocarcinoma 8 T3N0M0 26,9
31 63 M prostate adenocarcinoma 10 T4N0M0 .
32 57 M prostate adenocarcinoma 7 T4N0M0 25
33 72 M prostate adenocarcinoma 8 T4N0M0 16,8
34 70 M prostate adenocarcinoma 8 T3N0M0 0,5
35 75 M prostate adenocarcinoma 9 T3N0M0 98
36 62 M prostate adenocarcinoma 9 T4N0M0 .
37 63 M prostate adenocarcinoma 9 T4N0M0 91
38 53 M prostate adenocarcinoma 9 T4N0M0 161
39 63 M prostate adenocarcinoma 8 T3N0M0 13
40 44 M prostate adenocarcinoma 7 T3N0M0 .
41 69 M prostate normal (match of #8) . . . .
42 62 M prostate normal (match of #9) . . . .
43 66 M prostate normal (match of #12) . . . .
44 65 M prostate normal (match of #14) . . . .
45 69 M prostate normal (match of #18) . . . .
46 70 M prostate normal (match of #19) . . . .
47 70 M prostate normal (match of #29) . . . .
48 63 M prostate normal (match of #31) . . . .
49 44 M prostate normal (match of #40) . . . .
50 carbon
                 
TNM classification : prostate cancer (AJCC 5 th Edition)        

 

TNM Classification : Prostate carcinoma

T- Primary tumor

TX-primary tumor cannot be assessed

T0- No evidence of primary tumor

T1-Clinically inapparant tumor not palpable or visible by imaging

  • T1a-Tumor incidental histologic finding in 5% or less of tissue resected
  • T1b-Tumor incidental histologic finding in more 5% or less of tissue resected
  • T1c-Tumor identified by needle biospsy

T2-Tumor confined within the prostate

  • T2a-Tumor involves one lobe
  • T2b-Tumor involves two lobe

T3-Tumor extends through the prostate capsule

  • T3a-Extracapsular extension
  • T3b-Tumor invades seminal vesicle

T4-Tumor is fixed or invades adjacent structures other than seminal  vesicle: (blader neck,external sphincter, rectum, levator muscle and/or pelvic wall

N-Disntant lymph nodes

NX-Regional lymph nodes cannot be assessed

N0-No regional lymph node metastasis

N1-Regional lymph [h node metastasis]

M-Disntant metastasis

MX-Disntant metastasis cannot be assessed                                                  

M0-No disntant metastasis

M1-Disntant metastasis

  • M1a-Non-region lymph node(s)
  • M1b-Bone(s)
  • M1c-Other site(s)

General Information of the Tissue Array Slide

Applications

  • 􀁺 Immunohistochemistry
  • 􀁺 In situ hybridization, RNA or DNA
  • 􀁺 Fluorescent in situ hybridization (FISH)
  • 􀁺 In situ PCR, RNA or DNA
  • 􀁺 TUNEL for apoptosis (Recommended procedures in www.tissue-array.com -> protocol)

Storage and stability

  • 􀁺 Individual slide is paraffin-coated and put in an air-tight pack with inert gas.
  • 􀁺 Tissue array slides are shipped in room temperature.
  • 􀁺 If the slides are stored in 4 degree, they are good up to one year. How processed
  • 􀁺 Tissues were initially fixed with formalin except for some of the animal tissues.
  • 􀁺 Then, dehydrated with gradient ethanol; typically 1 hour each progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
  • 􀁺 Cleared by xylene, three changes for 1 hour each.
  • 􀁺 Infiltrated with 60°C paraffin, three changes for 1 hour each
  • 􀁺 Microtoming in 4 µm thickness and put on silane coating slide from Muto Pure Chemicals (Japan)

Before use

  • 􀁺 Dry slides for 1 hour in a oven at 60 degree.
  • 􀁺 Dewax slides in xylene for 4 minutes x 5 times
  • 􀁺 Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2 times each.
  • 􀁺 Immerse slides in tap water for 5 minutes

Slide orientation

  • 􀁺 In most of the slides with 59 or 60 cores, the orientation is as below unless indicated otherwise. #60 location is usually filled with carbon for orientation.

Shaded area

1 2 3 4 5 6 7 8 9 10
11 12 13 14 15 16 17 18 19 20
21 22 23 24 25 26 27 28 29 30
31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60